Fibrin Sealants Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Fibrin Sealant Market is segmented By Type (Spray, Patch) By Packaging Volume (2 ml, 4 ml, 10 ml, > 10 ml) By Age Group (Adults, Pediatrics) By Application (Hemostasis Adjunct, Sealant, Wound Closure and Repair, Others) By End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Market Overview

The global fibrin sealant market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Fibrin sealant is an adhesive material used as an adjunct to hemostasis to control bleeding, and tissue adhesion during surgical procedures, and to promote wound healing. Fibrin sealants are biocompatible and biodegradable and are made up of human blood components such as fibrinogen and thrombin. In addition to controlling hemostasis, fibrin sealants are majorly employed in anastomosis sealing, skin graft adhesion, and facial rhytidectomy.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Rising product approvals and launches

Fibrin sealants are the life-saving adhesive material used during the pre-op and post-op surgical procedures to control bleeding. With the rising surgical volumes worldwide the demand for sealants is expected to rise in the forecast period. Up until now, very few fibrin sealants have been approved by the FDA and are currently being commercially sold. Several companies have been currently developing fibrin sealants and receiving regulatory approvals which are expected to boost the market. 

For instance, on January 11, 2023, Grifolis, a plasma medicine business, released encouraging results from phase 3b clinical trials of Grifolis FS, a plasma-protein-based fibrin sealant in pediatric patients. The U.S. and Europe had previously approved Grifolis FS for use in adult patients, and these encouraging outcomes were anticipated to open the door for its regulatory approval in juvenile patients as well.   

In addition, on November 15, 2023, A Johnson & Johnson MedTech firm, Ethicon, announced that ETHIZIATM, a hemostatic adjunt composed of synthetic polymers, has been approved. In the clinical research, ETHIZIATM was found to be successful in 80% of the participants for reducing bleeding during open or minimally invasive surgery. Additionally, ETHIZIATM has been granted the CE mark, and its launch in the EMEA region is scheduled for 2024.

Moreover, on June 23, 2023, The phase I/II clinical trial assessing the safety and effectiveness of Sealantium Medical Ltd.'s innovative fibrin sealant, sFilm-FS, to reduce liver bleeding has been completed. . The study involved a comparison of sFilm-FS with TachoSil and was finished in the 3rd quarter of 2023. 

Further, the rising surgical procedural volumes, and growing demand for minimally invasive surgical procedures are the factors expected to drive the market over the forecast period.

Restraints

Factors such as the high cost of fibrin sealants, the risk of infection due to their allogenic nature, and the limited shelf life of the fibrin sealants are the factors expected to hamper the market over the forecast period. 

Segment Analysis

The global fibrin sealant market is segmented based on type, packaging volume, age group, application, end-usersand region.

The spray in type segment accounted for approximately 34.4% of the fibrin sealant market share

The spray in type segment is expected to hold the largest market share over the forecast period, this is because the majority of the companies operating in this market are offering spray type of fibrin sealant. The spray fibrin sealant can be easily applied during laparoscopic procedures and also minimizes the risk of foreign body contamination. Moreover, the spray sealant covers only the required surface uniformly without any irregularities. The first approved fibrin sealant is in liquid form which is aerosolized and can be sprayed, and most of the latter launched products are also based on the same technology. 

For instance, a major player in the market, Baxter has been offering a fibrin sealant called TISSEEL which is available in spray form. Another leading player, Ethicon a Johnson’s and Johnson’s company offer brands such as VISTASEAL which is available in spray form. Vivostat A/S offers a product called VivostatFibrin which is also available in spray form.

Geographical Analysis

North America accounted for approximately 45.30% of the market share 

North American region is expected to hold the largest market share over the forecast period owing to the rising strategic initiatives by major market players. Moreover, due to higher per capita healthcare spending North America is expected to lead the market. North America especially the United States is a very well-known hub for its strong presence of major market leaders. 

For instance, on January 31, 2023, according to an article published by The Commonwealth Fund, the healthcare spending and GDP in the U.S. are far higher than the other high-income countries. 

Moreover, sales expansion by major market leaders is expected to boost the target patient volume contributing to positive sales growth as well as market growth. For instance, on April 20, 2023, Corza Medical announced strategic plans to launch its product TachoSil directly to U.S. customers. The company sent its first shipment to the U.S. on April 14, 2023, in anticipation of driving solid growth in the company’s biosurgery business. Tachosil has also been approved for use in pediatric patients in the U.S. and has received a positive response for use in Europe.

Competitive Landscape

The major global players in the fibrin sealant market include Baxter., Johnson & Johnson Services, Inc., Corza Medical., Vivostat A/S, and CSL among others. 

Why Purchase the Report?

• To visualize the global fibrin sealant market segmentation based on type, packaging volume, age group, application, end-users, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of fibrin sealant market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global fibrin sealant market report would provide approximately 53 tables, 50 figures, and 187 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies